SlideShare a Scribd company logo
Normal Function
•Carbohydrates breakdown
•Produce NADPH
•Protects RBCs from oxidative
stress
•Reduces Glutathione
•Reduced glutathione
important for proper RBC
structure and to keep
hemoglobin in ferrous state.
The Role of Glucose-6 Dehydrogenase in Favism
Fatima Abdularahman, Nanaama O’Hene, Kene Ezeigwe, Flor Lema
Introduction
Glucose-6 Dehydrogenase (G6PD) is a cytosolic, regulatory
enzyme. Its main role is the catalysis of the first step of the
Pentose Phosphate Pathway of glucose metabolism which is the
oxidation of glucose-6-phosphate. In oxidizing
glucose-6-phosphate, G6PD reduces NADP to produce NADPH.
The production of NADPH is the most important function of
G6PD as NADPH is required for a variety of detoxification
reactions. More specifically, NADPH is responsible for the
reduction of glutathione. This reduced form of glutathione in
turn neutralizes free radicals to protect cells from oxidative
stress.
The clinical significance of G6PD lies in the variety of
enzymatic activity associated with the genetic diversity of G6PD
caused by various mutations. Many of these mutations lead to a
G6PD deficiency in the body which eventually leaves red blood
cells vulnerable to oxidative stress. Favism is one result of G6PD
deficiency as the consumption of fava beans causes oxidative
stress.
G6PD Gene
Glucose-6-phosphate dehydrogenase deficiency is a genetic
disorder. It is an X-linked recessive disorder that occurs most often
in males.
A mutation in the gene can change the amino acid
sequence in the protein that codes for the gene. Thereby,
disrupting the structure and function of the enzyme.
mutations lead to changes in single building blocks (amino acids)
that make up the glucose-6-phosphate dehydrogenase enzyme.
These changes disrupt the normal structure and function of the
enzyme or reduce the amount of the enzyme in cells.
This condition mainly affects red blood cells, which carry
oxygen from the lungs to tissues throughout the body.
Structure
G6PD exists as either a
dimer or a tetramer which
exists as a dimer of dimers.
Each subunit of the dimer
consists of two domains. The
smaller domain contains the coenzyme binding site
and is a dinucleotide-binding fold. The larger domain
is a beta + fold consisting of a nine-stranded beta
sheet. In humans, G6PD is normally in a rapid
dimer-tetramer equilibrium although high pH often
causes tetramers to dissociate into dimers. At low
pH, the equilibrium is shifted towards tetramers.
Mutations have been found to cause structural
deformities and deficiencies predominantly close to
the structural NAD+ interface.
Acknowledgements
First and foremost, we would like to thank Rutgers Robert Wood
Johnson Medical School and the Biomedical Careers Program for
hosting such a wonderfully engaging and educational summer
enrichment program. We would also like to thank our instructor
and T.A, Dr. Mohammad and Brian DePalma for their commitment
to teaching and guiding us throughout the length of the program.
Favism
Pathology: Mutation in G6PD gene → G6PD Deficiency → No NADPH → No reduced
glutathione (antioxidant) → free radicals not neutralized → oxidative stress → RBCs
damage
Cause: G6PD Deficiency
Main Symptoms:
- Jaundice- → Abundant hemoglobin breaks down into bilirubin (pigment) → liver overload
→ jaundice
→ hemolytic anemia (RBCS break down prematurely)
Triggered by: fava beans, legumes, antimalarial drugs, moth balls
Diagnosis: Umbilical cord blood, CBC, blood test, check bilirubin levels, reticulocyte count
First Line of Treatment: Phototherapy (for Neonatal Hyperbilirubinemia) and Dietary
restrictions
Other Treatment: Blood Transfusions
Carriers are partially protected against malaria because with less functional G6PD it is
difficult for the parasite to invade red blood cells. Parasites need the reduced glutathione
to grow.
Why Fava Beans?
Pamaquine (a purine glycoside) generates peroxides, which results in oxidative stress.
References
Au, Shannon Wn, Sheila Gover, Veronica Ms Lam, and Margaret J Adams. "Human Glucose-6-phosphate Dehydrogenase: The Crystal Structure
Reveals a Structural NADP Molecule and Provides Insights into Enzyme Deficiency." Structure 8.3: 293-303. Print.
Scopes, Deborah A., Jose M. Bautista, Claire E. Naylor, Margaret J. Adams, and Philip J. Mason. "Amino Acid
Substitutions at the Dimer Interface of Human Glucose-6-phosphate Dehydrogenase That Increase Thermostability
and Reduce the Stabilising Effect of NADP." Eur J Biochem European Journal of Biochemistry 251.1-2: 382-88. Print
www.ncbi.nlm.nih.gov/books/NBK22389/
http://g6pddeficiency.org/wp/#.VZb4F_lVikp

More Related Content

What's hot

Metabolic & endocrine emergencies 2
Metabolic & endocrine emergencies 2Metabolic & endocrine emergencies 2
Metabolic & endocrine emergencies 2
Be a Good Doctor Ali Dirie
 
Lab investigations of megaloblastic anaemia
Lab investigations of megaloblastic anaemiaLab investigations of megaloblastic anaemia
Lab investigations of megaloblastic anaemia
AarthiKB
 
Hmp shunt
Hmp shuntHmp shunt
Plasma proteins
Plasma proteinsPlasma proteins
Plasma proteins
Ramesh Gupta
 
Lec07 hm ppath
Lec07 hm ppathLec07 hm ppath
Lec07 hm ppathdream10f
 
Hmp shunt pathway
Hmp shunt pathwayHmp shunt pathway
Hmp shunt pathway
jagan vana
 
Plasma protein composition and function
Plasma protein composition and functionPlasma protein composition and function
Plasma protein composition and function
Dipesh Tamrakar
 
Plasma proteins
Plasma proteinsPlasma proteins
Plasma proteinsKinza Ayub
 
Hmp shunt
Hmp shuntHmp shunt
Hmp shunt
DRx Chaudhary
 
Plasma proteins
Plasma proteins Plasma proteins
Plasma proteins
Dr. Sanjeev Shrivastava
 
6 hmp+glucuronic
6 hmp+glucuronic6 hmp+glucuronic
6 hmp+glucuronicdream10f
 
Disorders of carbohydrate metabolism.
Disorders of carbohydrate metabolism.Disorders of carbohydrate metabolism.
Disorders of carbohydrate metabolism.
DanielWaweru5
 
Plasma proteins.
Plasma proteins.Plasma proteins.
Plasma proteins.
Dr.M.Prasad Naidu
 
Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...
Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...
Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...
Maryam Pazireh
 
PLASMA PROTEINS
PLASMA PROTEINSPLASMA PROTEINS
PLASMA PROTEINS
YESANNA
 
Serum proteins
Serum proteinsSerum proteins
Serum proteinsCsalam
 
Blood 2 functions of plasma proteins
Blood 2 functions of plasma proteinsBlood 2 functions of plasma proteins
Blood 2 functions of plasma proteinsFidel Kanyungu
 
plasma proteins
plasma proteinsplasma proteins
plasma proteins
Amna Sheikh
 
Biochemistry chart dr.g.bhanu prakash
Biochemistry chart dr.g.bhanu prakashBiochemistry chart dr.g.bhanu prakash
Biochemistry chart dr.g.bhanu prakash
Medvizz institute of medical education
 

What's hot (20)

Metabolic & endocrine emergencies 2
Metabolic & endocrine emergencies 2Metabolic & endocrine emergencies 2
Metabolic & endocrine emergencies 2
 
Lab investigations of megaloblastic anaemia
Lab investigations of megaloblastic anaemiaLab investigations of megaloblastic anaemia
Lab investigations of megaloblastic anaemia
 
Hmp shunt
Hmp shuntHmp shunt
Hmp shunt
 
Plasma proteins
Plasma proteinsPlasma proteins
Plasma proteins
 
Lec07 hm ppath
Lec07 hm ppathLec07 hm ppath
Lec07 hm ppath
 
Hmp shunt pathway
Hmp shunt pathwayHmp shunt pathway
Hmp shunt pathway
 
HEXOSE MONOPHOSPHATE SHUNT
HEXOSE MONOPHOSPHATE SHUNTHEXOSE MONOPHOSPHATE SHUNT
HEXOSE MONOPHOSPHATE SHUNT
 
Plasma protein composition and function
Plasma protein composition and functionPlasma protein composition and function
Plasma protein composition and function
 
Plasma proteins
Plasma proteinsPlasma proteins
Plasma proteins
 
Hmp shunt
Hmp shuntHmp shunt
Hmp shunt
 
Plasma proteins
Plasma proteins Plasma proteins
Plasma proteins
 
6 hmp+glucuronic
6 hmp+glucuronic6 hmp+glucuronic
6 hmp+glucuronic
 
Disorders of carbohydrate metabolism.
Disorders of carbohydrate metabolism.Disorders of carbohydrate metabolism.
Disorders of carbohydrate metabolism.
 
Plasma proteins.
Plasma proteins.Plasma proteins.
Plasma proteins.
 
Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...
Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...
Plasma Proteins For Therapeutic Use; An Introduction to Blood PLASMA & its Se...
 
PLASMA PROTEINS
PLASMA PROTEINSPLASMA PROTEINS
PLASMA PROTEINS
 
Serum proteins
Serum proteinsSerum proteins
Serum proteins
 
Blood 2 functions of plasma proteins
Blood 2 functions of plasma proteinsBlood 2 functions of plasma proteins
Blood 2 functions of plasma proteins
 
plasma proteins
plasma proteinsplasma proteins
plasma proteins
 
Biochemistry chart dr.g.bhanu prakash
Biochemistry chart dr.g.bhanu prakashBiochemistry chart dr.g.bhanu prakash
Biochemistry chart dr.g.bhanu prakash
 

Viewers also liked

W.E NOVAON 03
W.E NOVAON 03W.E NOVAON 03
W.E NOVAON 03
Ấn phẩm NOVAON
 
Enseñanza halloween
Enseñanza halloweenEnseñanza halloween
Enseñanza halloween
Estefania Bermudez
 
Parallel Session A - Presentation by Andy Stirling
Parallel Session A - Presentation by Andy StirlingParallel Session A - Presentation by Andy Stirling
Parallel Session A - Presentation by Andy Stirling
OECD Environment
 
Aspectos general de la empresa
Aspectos general de la empresaAspectos general de la empresa
Aspectos general de la empresa
Vladimir Baquero Marquez
 
Guidance for accounting: emissions intensity goals and goals relative to BAU ...
Guidance for accounting: emissions intensity goals and goals relative to BAU ...Guidance for accounting: emissions intensity goals and goals relative to BAU ...
Guidance for accounting: emissions intensity goals and goals relative to BAU ...
OECD Environment
 
5 29 13 morris county re mcpb minutes
5 29 13 morris county re mcpb minutes5 29 13 morris county re mcpb minutes
5 29 13 morris county re mcpb minutes
Kevin Sitlick
 
10 22 13 morris county planning board re minutes for the september 19, 2013 m...
10 22 13 morris county planning board re minutes for the september 19, 2013 m...10 22 13 morris county planning board re minutes for the september 19, 2013 m...
10 22 13 morris county planning board re minutes for the september 19, 2013 m...
Kevin Sitlick
 

Viewers also liked (7)

W.E NOVAON 03
W.E NOVAON 03W.E NOVAON 03
W.E NOVAON 03
 
Enseñanza halloween
Enseñanza halloweenEnseñanza halloween
Enseñanza halloween
 
Parallel Session A - Presentation by Andy Stirling
Parallel Session A - Presentation by Andy StirlingParallel Session A - Presentation by Andy Stirling
Parallel Session A - Presentation by Andy Stirling
 
Aspectos general de la empresa
Aspectos general de la empresaAspectos general de la empresa
Aspectos general de la empresa
 
Guidance for accounting: emissions intensity goals and goals relative to BAU ...
Guidance for accounting: emissions intensity goals and goals relative to BAU ...Guidance for accounting: emissions intensity goals and goals relative to BAU ...
Guidance for accounting: emissions intensity goals and goals relative to BAU ...
 
5 29 13 morris county re mcpb minutes
5 29 13 morris county re mcpb minutes5 29 13 morris county re mcpb minutes
5 29 13 morris county re mcpb minutes
 
10 22 13 morris county planning board re minutes for the september 19, 2013 m...
10 22 13 morris county planning board re minutes for the september 19, 2013 m...10 22 13 morris county planning board re minutes for the september 19, 2013 m...
10 22 13 morris county planning board re minutes for the september 19, 2013 m...
 

Similar to BCP G6PD-2

G6PD glucose 6 phosphate dehydrogens deficiency
 G6PD  glucose 6 phosphate dehydrogens deficiency G6PD  glucose 6 phosphate dehydrogens deficiency
G6PD glucose 6 phosphate dehydrogens deficiency
SomnathKamble6
 
G6PD Deficiency
G6PD DeficiencyG6PD Deficiency
G6PD Deficiency
M S
 
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhptCOG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
mbashapatrick09
 
G6pd
G6pdG6pd
G6pd
S. Ismat
 
G6PD disease.pptx
G6PD disease.pptxG6PD disease.pptx
G6PD disease.pptx
sandeep singh
 
pentosephosphate.ppt
pentosephosphate.pptpentosephosphate.ppt
pentosephosphate.ppt
El Saadany Mohamad
 
Blood 111.pptx
Blood 111.pptxBlood 111.pptx
Blood 111.pptx
PariaMotahari1
 
G6 pd dificiency_anemia_new
G6 pd dificiency_anemia_newG6 pd dificiency_anemia_new
G6 pd dificiency_anemia_new
αямαи мαℓιк
 
G6pd
G6pdG6pd
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
HariharanK48
 
PP pathway.pdf
PP pathway.pdfPP pathway.pdf
PP pathway.pdf
MDSHEMIMHUSSAIN
 
G6pd deficiency
G6pd deficiencyG6pd deficiency
G6pd deficiency
DrAbdulrazzaqAlagbar
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC Enzymopathies
Pradeep Singh Narwat
 
2.2 pentose and uronic pathway.pptx
2.2 pentose and uronic pathway.pptx2.2 pentose and uronic pathway.pptx
2.2 pentose and uronic pathway.pptx
Fatima117039
 
Carbohydrate Metabolism Part 2
Carbohydrate Metabolism Part 2Carbohydrate Metabolism Part 2
Carbohydrate Metabolism Part 2
ShibleeZaman
 
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
TunTunWin34
 
HMP SHUNT PATHWAY
HMP SHUNT PATHWAYHMP SHUNT PATHWAY
HMP SHUNT PATHWAYYESANNA
 

Similar to BCP G6PD-2 (20)

G6PD glucose 6 phosphate dehydrogens deficiency
 G6PD  glucose 6 phosphate dehydrogens deficiency G6PD  glucose 6 phosphate dehydrogens deficiency
G6PD glucose 6 phosphate dehydrogens deficiency
 
G6PD Deficiency
G6PD DeficiencyG6PD Deficiency
G6PD Deficiency
 
G6pd
G6pdG6pd
G6pd
 
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhptCOG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
 
G6pd
G6pdG6pd
G6pd
 
G6PD disease.pptx
G6PD disease.pptxG6PD disease.pptx
G6PD disease.pptx
 
pentosephosphate.ppt
pentosephosphate.pptpentosephosphate.ppt
pentosephosphate.ppt
 
Blood 111.pptx
Blood 111.pptxBlood 111.pptx
Blood 111.pptx
 
G6 pd dificiency_anemia_new
G6 pd dificiency_anemia_newG6 pd dificiency_anemia_new
G6 pd dificiency_anemia_new
 
G6pd
G6pdG6pd
G6pd
 
hmp-shunt
 hmp-shunt hmp-shunt
hmp-shunt
 
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
 
PP pathway.pdf
PP pathway.pdfPP pathway.pdf
PP pathway.pdf
 
G6pd deficiency
G6pd deficiencyG6pd deficiency
G6pd deficiency
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC Enzymopathies
 
2.2 pentose and uronic pathway.pptx
2.2 pentose and uronic pathway.pptx2.2 pentose and uronic pathway.pptx
2.2 pentose and uronic pathway.pptx
 
Carbohydrate Metabolism Part 2
Carbohydrate Metabolism Part 2Carbohydrate Metabolism Part 2
Carbohydrate Metabolism Part 2
 
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
 
G6PD Deficiency Anaemai
G6PD Deficiency AnaemaiG6PD Deficiency Anaemai
G6PD Deficiency Anaemai
 
HMP SHUNT PATHWAY
HMP SHUNT PATHWAYHMP SHUNT PATHWAY
HMP SHUNT PATHWAY
 

BCP G6PD-2

  • 1. Normal Function •Carbohydrates breakdown •Produce NADPH •Protects RBCs from oxidative stress •Reduces Glutathione •Reduced glutathione important for proper RBC structure and to keep hemoglobin in ferrous state. The Role of Glucose-6 Dehydrogenase in Favism Fatima Abdularahman, Nanaama O’Hene, Kene Ezeigwe, Flor Lema Introduction Glucose-6 Dehydrogenase (G6PD) is a cytosolic, regulatory enzyme. Its main role is the catalysis of the first step of the Pentose Phosphate Pathway of glucose metabolism which is the oxidation of glucose-6-phosphate. In oxidizing glucose-6-phosphate, G6PD reduces NADP to produce NADPH. The production of NADPH is the most important function of G6PD as NADPH is required for a variety of detoxification reactions. More specifically, NADPH is responsible for the reduction of glutathione. This reduced form of glutathione in turn neutralizes free radicals to protect cells from oxidative stress. The clinical significance of G6PD lies in the variety of enzymatic activity associated with the genetic diversity of G6PD caused by various mutations. Many of these mutations lead to a G6PD deficiency in the body which eventually leaves red blood cells vulnerable to oxidative stress. Favism is one result of G6PD deficiency as the consumption of fava beans causes oxidative stress. G6PD Gene Glucose-6-phosphate dehydrogenase deficiency is a genetic disorder. It is an X-linked recessive disorder that occurs most often in males. A mutation in the gene can change the amino acid sequence in the protein that codes for the gene. Thereby, disrupting the structure and function of the enzyme. mutations lead to changes in single building blocks (amino acids) that make up the glucose-6-phosphate dehydrogenase enzyme. These changes disrupt the normal structure and function of the enzyme or reduce the amount of the enzyme in cells. This condition mainly affects red blood cells, which carry oxygen from the lungs to tissues throughout the body. Structure G6PD exists as either a dimer or a tetramer which exists as a dimer of dimers. Each subunit of the dimer consists of two domains. The smaller domain contains the coenzyme binding site and is a dinucleotide-binding fold. The larger domain is a beta + fold consisting of a nine-stranded beta sheet. In humans, G6PD is normally in a rapid dimer-tetramer equilibrium although high pH often causes tetramers to dissociate into dimers. At low pH, the equilibrium is shifted towards tetramers. Mutations have been found to cause structural deformities and deficiencies predominantly close to the structural NAD+ interface. Acknowledgements First and foremost, we would like to thank Rutgers Robert Wood Johnson Medical School and the Biomedical Careers Program for hosting such a wonderfully engaging and educational summer enrichment program. We would also like to thank our instructor and T.A, Dr. Mohammad and Brian DePalma for their commitment to teaching and guiding us throughout the length of the program. Favism Pathology: Mutation in G6PD gene → G6PD Deficiency → No NADPH → No reduced glutathione (antioxidant) → free radicals not neutralized → oxidative stress → RBCs damage Cause: G6PD Deficiency Main Symptoms: - Jaundice- → Abundant hemoglobin breaks down into bilirubin (pigment) → liver overload → jaundice → hemolytic anemia (RBCS break down prematurely) Triggered by: fava beans, legumes, antimalarial drugs, moth balls Diagnosis: Umbilical cord blood, CBC, blood test, check bilirubin levels, reticulocyte count First Line of Treatment: Phototherapy (for Neonatal Hyperbilirubinemia) and Dietary restrictions Other Treatment: Blood Transfusions Carriers are partially protected against malaria because with less functional G6PD it is difficult for the parasite to invade red blood cells. Parasites need the reduced glutathione to grow. Why Fava Beans? Pamaquine (a purine glycoside) generates peroxides, which results in oxidative stress. References Au, Shannon Wn, Sheila Gover, Veronica Ms Lam, and Margaret J Adams. "Human Glucose-6-phosphate Dehydrogenase: The Crystal Structure Reveals a Structural NADP Molecule and Provides Insights into Enzyme Deficiency." Structure 8.3: 293-303. Print. Scopes, Deborah A., Jose M. Bautista, Claire E. Naylor, Margaret J. Adams, and Philip J. Mason. "Amino Acid Substitutions at the Dimer Interface of Human Glucose-6-phosphate Dehydrogenase That Increase Thermostability and Reduce the Stabilising Effect of NADP." Eur J Biochem European Journal of Biochemistry 251.1-2: 382-88. Print www.ncbi.nlm.nih.gov/books/NBK22389/ http://g6pddeficiency.org/wp/#.VZb4F_lVikp